<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02023476</url>
  </required_header>
  <id_info>
    <org_study_id>HEM</org_study_id>
    <nct_id>NCT02023476</nct_id>
  </id_info>
  <brief_title>Neurologic Examination of Wide and Narrow Tourniquets</brief_title>
  <acronym>HEM</acronym>
  <official_title>Nerve Function in Healthy Human Volunteers With Two Different Tourniquets</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nerve injury is a serious potential complication associated with the clinical use of&#xD;
      exsanguinating tourniquets in surgery. Recently, a novel narrow tourniquet has been proposed,&#xD;
      with the claim that it may cause less compression of the nerves. We performed an in vivo&#xD;
      comparison of a standard wide tourniquet with the new, narrow tourniquet. Our study&#xD;
      specifically looked at neurologic markers in the upper extremity.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The HemaClear ™ OHK Medical Device HemaClear™, approved by FDA, consists of a silicon ring&#xD;
      wrapped in a stockinet sleeve and pull straps (Fig.1). It performs three functions - blood&#xD;
      removal (exsanguinations), arterial flow occlusion, and placement of sterile stockinet 30.&#xD;
      The ring is placed on the extremity and then straps are pulled proximally. The silicone ring&#xD;
      rolls up the limb while the stockinet sleeve unfolds onto the limb. During the rolling up&#xD;
      process, the ring exerts pressure and squeezes the blood away from the limb. Application of&#xD;
      the device takes less than a minute.&#xD;
&#xD;
      The technique behind this device is fundamentally different from classic pneumatic&#xD;
      tourniquets, as pressure is exercised by only a single silicon ring so that the profile is&#xD;
      very small.&#xD;
&#xD;
      Zimmer A.T.S.®3000 The A.T.S.®3000 is an automatic broad tourniquet system with a Limb&#xD;
      Occlusion Pressure (LOP) feature. It is the latest innovation in tourniquet technology and&#xD;
      has FDA approval. It was invented by McEwen 4 and the basic function is described in several&#xD;
      clinical trials and publications 28. The main difference to other pneumatic tourniquets is&#xD;
      the LOP and the Recommended tissue pressure (RTP) feature. These parameters are suitable to&#xD;
      optimize the pressure force on the tourniquet for each individual patient. The LOP is&#xD;
      detected before inflating the tourniquet and the RTP is the LOP plus a safety margin to&#xD;
      guarantee a blood free field (Operator &amp; Service Manual Zimmer A.T.S.® 3000 Automatic&#xD;
      tourniquet system REF 60-3000-101-00).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nerve compression</measure>
    <time_frame>20 Minutes</time_frame>
    <description>mg/mm2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nerve compression</measure>
    <time_frame>20 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Nerve Compression</condition>
  <arm_group>
    <arm_group_label>wide tourniquet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(Zimmer A.T.S.®3000 ) wide tourniquet MRI intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>narrow tourniquet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HemaClear ™ tourniquet MRI intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>MRI- imaging on the upper arm</description>
    <arm_group_label>narrow tourniquet</arm_group_label>
    <arm_group_label>wide tourniquet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  self defined Caucasian&#xD;
&#xD;
          -  clinically healthy&#xD;
&#xD;
          -  BMI of ≤ 30,&#xD;
&#xD;
          -  a systolic arterial blood pressure ≤190 mmHg,&#xD;
&#xD;
          -  no rash or dermatologic condition or tattoos which may interfere with the placement&#xD;
             site&#xD;
&#xD;
          -  no neurovascular impairment.&#xD;
&#xD;
          -  all female participants received a pregnancy test at the initial screening visit.&#xD;
&#xD;
          -  Study population was restricted to Caucasians to enable an assessment of device caused&#xD;
             redness or skin lesions, not possible in a mixed study population.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florian M Kovar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MUW</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>RIAO, Sinai Hospital Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21215-5271</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <study_first_submitted>December 17, 2013</study_first_submitted>
  <study_first_submitted_qc>December 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2013</study_first_posted>
  <last_update_submitted>January 9, 2014</last_update_submitted>
  <last_update_submitted_qc>January 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Dr. Florian M Kovar</investigator_full_name>
    <investigator_title>Univ. Lektor Dr. med. univ</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

